1. Home
  2. HIHO vs OGEN Comparison

HIHO vs OGEN Comparison

Compare HIHO & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highway Holdings Limited

HIHO

Highway Holdings Limited

HOLD

Current Price

$0.92

Market Cap

4.3M

Sector

Industrials

ML Signal

HOLD

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.86

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIHO
OGEN
Founded
1990
1996
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
3.6M
IPO Year
2002
2010

Fundamental Metrics

Financial Performance
Metric
HIHO
OGEN
Price
$0.92
$0.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
48.2K
409.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
13.33%
N/A
EPS Growth
N/A
82.57
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.11
52 Week High
$2.21
$9.16

Technical Indicators

Market Signals
Indicator
HIHO
OGEN
Relative Strength Index (RSI) 43.42 56.45
Support Level $0.89 $0.82
Resistance Level $1.21 $0.90
Average True Range (ATR) 0.06 0.08
MACD 0.01 0.02
Stochastic Oscillator 31.54 56.49

Price Performance

Historical Comparison
HIHO
OGEN

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: